Disc Medicine, Inc.
IRON
$59.14
-$0.85-1.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 112.71% | 112.48% | 104.85% | 57.04% | 36.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 91.37% | 106.04% | 99.05% | 26.97% | 16.28% |
| Operating Income | -91.37% | -106.04% | -99.05% | -26.97% | -16.28% |
| Income Before Tax | -106.42% | -134.92% | -109.93% | -26.06% | -24.35% |
| Income Tax Expenses | -50.00% | -10.53% | -13.33% | 2,280.00% | 450.00% |
| Earnings from Continuing Operations | -105.49% | -134.30% | -109.65% | -26.48% | -24.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -105.49% | -134.30% | -109.65% | -26.48% | -24.93% |
| EBIT | -91.37% | -106.04% | -99.05% | -26.97% | -16.28% |
| EBITDA | -91.16% | -105.84% | -99.48% | -27.01% | -16.34% |
| EPS Basic | -63.77% | -99.39% | -53.53% | 5.84% | -1.82% |
| Normalized Basic EPS | -62.20% | -99.89% | -53.72% | 6.16% | 4.72% |
| EPS Diluted | -63.77% | -99.39% | -53.53% | 5.84% | -1.82% |
| Normalized Diluted EPS | -62.20% | -99.89% | -53.72% | 6.16% | 4.72% |
| Average Basic Shares Outstanding | 25.47% | 17.51% | 36.55% | 34.32% | 22.69% |
| Average Diluted Shares Outstanding | 25.47% | 17.51% | 36.55% | 34.32% | 22.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |